Literature DB >> 12770972

Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling.

R A Grigorian1, A Castellarin, R Fegan, C Seery, L V Del Priore, S Von Hagen, M A Zarbin.   

Abstract

AIMS: To compare conventional methods of epiretinal membrane peeling with viscodissection.
METHODS: 154 eyes with proliferative diabetic retinopathy (PDR) that underwent pars plana vitrectomy with membrane dissection (89 traditional, 65 viscodissection) were studied retrospectively. Incidence of retinal breaks (RBs), length of time under anaesthesia, postoperative intraocular pressure, retinal reattachment rate, and final visual acuity (VA) were measured.
RESULTS: To compare cases of similar complexity, a "complexity score" was defined. The average complexity score for cases done with and without viscodissection was 4.7 and 3.2, respectively. The mean frequency of RBs in eyes undergoing viscodissection was 0.43 (SD 0.5) v 0.14 (0.35) RBs/eye without viscodissection. In complex cases, the frequency of posterior/peripheral RBs was 0.31 (0.47)/0.13 (0.34) RBs/eye, respectively, with viscodissection v 0.12 (0.33)/0.23 (0.43) RBs/eye without viscodissection. None of these differences were statistically significant. The average preoperative/postoperative VA (logMAR) in the viscodissection cohort was 1.7/1.3 (range 0.3 to >1.9/0.1 to >1.9) v 1.4/1 (range 0.48 to >1.9/0.1 to >1.9) in the non-viscodissection cohort, among eyes with 6 months of follow up. Anaesthesia duration was significantly shorter for cases done without viscodissection (p=0.03), but cases done with viscodissection were significantly more complex than cases done without viscodissection (p<0.0001).
CONCLUSION: Viscodissection appears to be a safe and effective alternative technique in eyes with PDR. Owing to the retrospective nature of the study, additional studies are warranted.

Entities:  

Mesh:

Year:  2003        PMID: 12770972      PMCID: PMC1771714          DOI: 10.1136/bjo.87.6.737

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Viscodelamination at the vitreoretinal juncture in severe diabetic eye disease.

Authors:  D McLeod; C R James
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

2.  Healon GV in posterior segment surgery.

Authors:  S Crafoord; S Stenkula
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-08

3.  [Healon as an emergency aid].

Authors:  H Neubauer
Journal:  Klin Monbl Augenheilkd       Date:  1983-04       Impact factor: 0.700

4.  Use of Healon in anterior segment trauma.

Authors:  E R Rashid; G O Waring
Journal:  Ophthalmic Surg       Date:  1982-03

5.  The use of sodium hyaluronate (Healon) in human anterior segment surgery.

Authors:  L G Pape; E A Balazs
Journal:  Ophthalmology       Date:  1980-07       Impact factor: 12.079

6.  Use of Na-hyaluronate in anterior segment eye surgery.

Authors:  D Miller; R Stegmann
Journal:  J Am Intraocul Implant Soc       Date:  1980-01

7.  The use of sodium-hyaluronate (Healon) in the treatment of retinal detachment.

Authors:  S Stenkula; L Ivert; I Gislason; R Tornquist; L Weijdegard
Journal:  Ophthalmic Surg       Date:  1981-06

8.  Hyaluronic acid and replacement of vitreous and aqueous humor.

Authors:  E A Balazs; M I Freeman; R Klöti; G Meyer-Schwickerath; F Regnault; D B Sweeney
Journal:  Mod Probl Ophthalmol       Date:  1972

9.  Viscoelastic materials in veterinary ophthalmology.

Authors:  D.A. Wilkie; A.M. Willis
Journal:  Vet Ophthalmol       Date:  1999       Impact factor: 1.644

10.  Vitrectomy for complications of diabetic retinopathy.

Authors:  R G Michels
Journal:  Arch Ophthalmol       Date:  1978-02
View more
  14 in total

1.  Silicone oil in diabetic vitrectomy.

Authors:  D McLeod
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

2.  Viscosurgery in diabetic vitrectomy.

Authors:  D McLeod
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

3.  Clinical and histological features of epiretinal membrane after diabetic vitrectomy.

Authors:  Yung-Ray Hsu; Chung-May Yang; Po-Ting Yeh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-15       Impact factor: 3.117

4.  Design of 3-DOF force sensing micro-forceps for robot assisted vitreoretinal surgery.

Authors:  Berk Gonenc; James Handa; Peter Gehlbach; Russell H Taylor; Iulian Iordachita
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

5.  3-DOF Force-Sensing Micro-Forceps for Robot-Assisted Membrane Peeling: Intrinsic Actuation Force Modeling.

Authors:  Anzhu Gao; Berk Gonenc; Jiangzhen Guo; Hao Liu; Peter Gehlbach; Iulian Iordachita
Journal:  Proc IEEE RAS EMBS Int Conf Biomed Robot Biomechatron       Date:  2016-07-28

6.  Vitrectomy for myopic posterior retinoschisis or foveal detachment.

Authors:  Akito Hirakata; Tetsuo Hida
Journal:  Jpn J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.447

7.  Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Emanuele Di Bartolo; Andrea Vento; Sofia Miniaci; George Williams
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-20       Impact factor: 3.117

8.  Evaluation of a Micro-Force Sensing Handheld Robot for Vitreoretinal Surgery.

Authors:  Berk Gonenc; Marcin A Balicki; James Handa; Peter Gehlbach; Cameron N Riviere; Russell H Taylor; Iulian Iordachita
Journal:  Rep U S       Date:  2012-12-20

9.  A Comparative Study for Robot Assisted Vitreoretinal Surgery: Micron vs. the Steady-Hand Robot.

Authors:  Berk Gonenc; James Handa; Peter Gehlbach; Russell H Taylor; Iulian Iordachita
Journal:  IEEE Int Conf Robot Autom       Date:  2013

10.  Perfluorocarbon-perfused 23 gauge three-dimensional vitrectomy for complicated diabetic tractional retinal detachment.

Authors:  Raul Velez-Montoya; Jose Luis Guerrero-Naranjo; Gerardo Garcia-Aguirre; Virgilio Morales-Cantón; Jans Fromow-Guerra; Hugo Quiroz-Mercado
Journal:  Clin Ophthalmol       Date:  2011-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.